After spending time in academia and exploring the unknown, the industry often seems too limited scientifically to those finishing a PhD. We will explore the bridge between the industry and academia to understand how basic scientific findings take shape into products and strategies. We will also follow the career paths of researchers who are in academia or outside of it, professionals that made their choice, followed it through and come to us to tell all about it.
Academia or not? And if not, what else? That is a tough nut to crack. Call us the nutcrackers.
All content for mAcademia - Science, More than Just Academia. is the property of Elena Itskovich & Ofer Yizhar Barnea and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
After spending time in academia and exploring the unknown, the industry often seems too limited scientifically to those finishing a PhD. We will explore the bridge between the industry and academia to understand how basic scientific findings take shape into products and strategies. We will also follow the career paths of researchers who are in academia or outside of it, professionals that made their choice, followed it through and come to us to tell all about it.
Academia or not? And if not, what else? That is a tough nut to crack. Call us the nutcrackers.
#50 - Finding new paths paved with proteomics - with Gali Arad and Eran Seger from Protai
mAcademia - Science, More than Just Academia.
53 minutes 36 seconds
3 years ago
#50 - Finding new paths paved with proteomics - with Gali Arad and Eran Seger from Protai
Gali Arad and Eran Seger from Protai had talked to us about moving from their previous life in tech and academia into the fast pace of illuminating the druggable Proteome for better cures.
Eran Seger is the Co-Founder and CEO of Protai, a fast-growing biotech startup sitting on the intersection of proteomics and machine learning to develop novel therapeutics for a variety of complex diseases. Eran is an experienced technology executive and entrepreneur with a strong technical background and over 15 years of tech leadership positions at the Israeli Intelligence forces and HighTech.
Gali Arad, PhD is a Computational Biologist and the first employee of Protai, a drug discovery startup combining AI and proteomics to create intelligence-driven pharma. She is an end-to-end computational biology scientist, with broad experience in systems biology, data analysis, hands-on technological practice, and clinical samples handling. In her current role, Gali leads the scientific research, focused on target discovery and prioritization, and the collection and curation of Protai’s data warehouse. She holds a Ph.D from Tel Aviv University, applying mass-spectrometry-based proteomics to study cancer heterogeneity. Her findings were published in top-tier scientific journals and emphasized the added value of clinical proteomics in the study of cancer.
Music:
Funkorama Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0 License
http://creativecommons.org/licenses/by/3.0/
mAcademia - Science, More than Just Academia.
After spending time in academia and exploring the unknown, the industry often seems too limited scientifically to those finishing a PhD. We will explore the bridge between the industry and academia to understand how basic scientific findings take shape into products and strategies. We will also follow the career paths of researchers who are in academia or outside of it, professionals that made their choice, followed it through and come to us to tell all about it.
Academia or not? And if not, what else? That is a tough nut to crack. Call us the nutcrackers.
